Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Buy Cybin Stock – CYBN Stock Quote Today & Investment Insights - Public.com
CYBN - Cybin Inc Stock Price Forecast 2026, 2027, 2030 to 2050 - StockScan
Cybin Inc. Stock Overview — CYBN Summary & Analysis — Roic AI
Cybin Inc. Stock Report — CYBN Analysis — Roic AI
Cybin Inc CYBN Q2 2026 Earnings Call - YouTube
How to Buy Cybin Stock | Invest in CYBN
Cybin (CYBN) launches US$100M at-the-market share program | CYBN Stock News
CYBN (Cybin Inc.) – Market News – TrendSpider
QUARTERLY IN DEPTH INVESTMENT ANALYSIS UPDATE - CYBIN INC (NYSE: CYBN ...
CYBN
Cybin Stock Analysis 2025 | Why CYBN Could Be the Future of Psychedelic ...
CYBN Stock | Message Board | Cybin Inc - Investors Hangout
CYBN (Cybin Inc.) Stock Predictions for 2024 - YouTube
CYBIN INC POTENTIAL BOUNCE | CYBN STOCK NEWS - YouTube
CYBN Stock Forecast 2024, 2025, 2026, 2027, 2028, 2030-2050
CYBN STOCK ANALYSIS | CYBIN INC BIG SWING - YouTube
Cybin's CYB003 Depression Drug Study Gets Australian Approval | CYBN ...
CYBN Stock Forecast: Projections From 2025 To 2040
QUARTERLY IN DEPTH INVESTMENT ANALYSIS - CYBIN INC (NYSE: CYBN ...
Cybin Announces $175M Registered Direct Offering at $6.51 | CYBN Stock News
CYBN Cybin Stock: 3 Price Scenarios After Pomerantz Probe - Wednesday ...
Cybin Inc. (NEO: CYBN) in Prime Position as Interest in Psychedelic ...
Cybin (CYBN.NEO) approved for first-in-human dosing - Equity.Guru
Cybin Goes Public on NEO Exchange | INN
Cybin Launches Phase 3 Trial for Depression Drug After Breakthrough 71% ...
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic ...
POTENTIAL UPSIDE | $CYBN STOCK ANALYSIS | CYBIN INC STOCK | CYBIN STOCK ...
UK Approves Cybin's Phase 3 Depression Treatment Trial Across 60 Global ...
Cybin Inc. - Prism MarketView
Cybin Goes Public on the NEO Exchange | Psychedelic Finance
Cybin Inc. (CYBN) Dividend History, Date, and Yield | CoinCodex
What are the Porter's Five Forces of Cybin Inc. (CYBN)? – DCFmodeling.com
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 ...
Cybin Shareholders Approve All Directors, Auditor at Annual Meeting ...
Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation ...
Guggenheim Initiates Coverage of Cybin (CYBN) with Buy Recommendation
Cybin Inc. (NEO:CYBN) (NYSE:CYBN) progressing “Psychedelics to ...
CYBIN Inc $CYBN CEO Interview | Benzinga - YouTube
Cybin (CYBN) Price Target Increased by 44.08% to 5.39 | Nasdaq
Cybin Phase 3 Trial Advances as FDA Prioritizes Psychedelic Reviews ...
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E ...
Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a ...
Cybin Inc. (AMEX:CYBN) Seasonal Chart | Equity Clock
Cybin Inc. - PRISM MarketView
How Cybin (CYBN.NEO), Red Light Holland (TRIP.C) and MindMed (MMED.NEO ...
Cybin Inc. 2023 FQ1 - Results - Earnings Call Presentation (NYSE:CYBN ...
Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025
Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For ...
Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough ...
Cybin Inc. (CYBN) DCF Excel Template – DCFmodeling.com
Cybin Receives FDA Breakthrough Therapy Designation - Long Term Biotech ...
Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of ...
Cybin (CYBN) Is Quietly Rewriting the Future of Mental Healthcare ...
Cybin (CYBN.NE) Shakes Up Senior Management Ahead of Buildout - Equity.Guru
The Top Companies Leading Psilocybin Research & Therapy
Cybin Completes Phase 2 GAD Trial Enrollment, Advances Phase 3 MDD ...
Cybin Leads in Aligning with FDA's New Psychedelic Drugs Guidelines: A ...
Cybin (CYBN.NE) Completes 51st Pre-Clinical Psychedelic Molecule Study ...
Cybin (CYBN) Stock Rises Following Positive Trial Results
Cybin Stock: Optimism Quickly Fades (NYSE:CYBN) | Seeking Alpha
Stock Market News Live Feed | Stock Titan
Cybin ($CYBN) Announces Advancement in DMT Therapies with First Human ...
Cybin Inc. (NEO:CYBN.NE) Seasonal Chart | Equity Clock
Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is ...
Cybin Tackles Major Depressive Disorder with Psychedelic-Based ...
Cybin, Inc. (NYSE:CYBN) (NEO:CYBN) - YouTube
Cybin (CYBN.NE) subsidiary Adelia achieves earn-out milestones, stock ...
Cybin Enters Definitive Agreement To Acquire Small Pharma | IBTimes
Cybin Inc. (CYBN) - Bronstein, Gewirtz & Grossman, LLC
CybinInc on Twitter: "Cybin will commence trading on the @NYSE tomorrow ...
Cybin ($CYBN) | Company Profile - YouTube
Cybin Inc (CYBN) Stock Message Board | InvestorsHub
Cybin (CYBN) Sets Stage for Phase 3 Trial for Major Depressive Disorder ...
Cybin’s Psilocybin Breakthrough | An Interview with CEO Doug Drysdale ...
Cybin: Upgrade To Hold - But Don't Get Too Carried Away (NYSE:CYBN ...
Cybin Inc. | INN
Cybin Inc. Common Shares (CYBN) Stock Price, News, Quote & History ...
Cybin (CYBN.NE) in Prime Position as Interest in Psychedelic Medicine ...
Cybin Inc. Accelerates Toward Psychedelic Therapy Commercialization ...
Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up
Generating the Data: Cybin Prepares for Phase 3 | $CYBN - YouTube
Cybin Receives FDA Breakthrough Therapy Designation for its Novel ...
How Cybin (CYBN.NE) is integrating new brain imaging technology with ...
Cybin (CYBN) Price, Quote & Forecast - Get it Now - AInvest
Cybin logo in transparent PNG format
Cybin Announces Approval of First-in-Human Dosing of its Proprietary ...
The Psychedelic Sector has Reached "Escape Velocity" | An interview ...
Cybin Inc. (NEO: CYBN) at Forefront of Psychedelic
Cybin (CLXPF CYBN) Banks $30 Million Overnight. | Internet | Biotech ...
Cybin Achieves Research and Development Milestones Ahead of Projected ...
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human ...
Penny Stocks To Buy Now? 4 Biotech Stocks To Watch This Week
Cybin Announces Successful Completion of In Vivo Preclinical Studies ...
